Polycythemia vera and secondary polycythemia: Treatment and . . . - UpToDate Clinical manifestations and diagnosis of polycythemia vera; Diagnostic approach to the patient with erythrocytosis polycythemia; Essential thrombocythemia: Treatment and prognosis; Initial assessment and management of acute stroke
Clinical manifestations and diagnosis of polycythemia vera - UpToDate Polycythemia vera (PV, polycythemia rubra vera, maladie de Vaquez) is one of the chronic myeloproliferative neoplasms (MPNs), which are collectively characterized by clonal proliferation of myeloid cells with variable morphologic maturity and hematopoietic efficiency
Polycythemia vera - UpToDate An overview of the four classic myeloproliferative neoplasms (MPN): polycythemia vera, essential thrombocythemia, primary myelofibrosis, and chronic myeloid leukemia will be presented here Detailed information …
UpToDate The page provides detailed information on the treatment and prognosis of polycythemia vera and secondary polycythemia
UpToDate A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications Leukemia 2010; 24:1574
Management of primary myelofibrosis - UpToDate The presence of JAK2V617F in primary myelofibrosis or its allele burden in polycythemia vera predicts chemosensitivity to hydroxyurea Am J Hematol 2008; 83:363 Benbassat J, Penchas S, Ligumski M Splenectomy in patients with agnogenic myeloid metaplasia: an analysis of 321 published cases
Polycythemia vera: 2024 update on diagnosis, risk‐stratification, and . . . Disease Overview: Polycythemia vera (PV) is a JAK2-mutated myeloproliferative neoplasm characterized by clonal erythrocytosis; other features include leukocytosis, thrombocytosis, splenomegaly, pruritus, constitutional symptoms, microcirculatory disturbances, and increased risk of thrombosis and progression into myelofibrosis
RELATED TOPICS - UpToDate Diagnosing the specific cause of polycythemia is important for proper management of the patient This topic discusses the causes of polycythemia and our approach to evaluation and diagnosis The approach to confirming a diagnosis of polycythemia vera is discussed separately
Prognosis and treatment of polycythemia vera - UpToDate A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications Leukemia 2010; 24:1574
Clinical manifestations and diagnosis of polycythemia vera Polycythemia vera (PV, polycythemia rubra vera, maladie de Vaquez) is one of the chronic myeloproliferative neoplasms (MPNs), which are collectively characterized by clonal proliferation of myeloid cells with variable morphologic maturity and hematopoietic efficiency
Overview of the myeloproliferative neoplasms - UpToDate An overview of the four classic myeloproliferative neoplasms (MPN): polycythemia vera, essential thrombocythemia, primary myelofibrosis, and chronic myeloid leukemia will be presented here Detailed information on each of these disorders is presented separately
Clinical manifestations and diagnosis of polycythemia vera - UpToDate UpToDate, electronic clinical resource tool for physicians and patients that provides information on Adult Primary Care and Internal Medicine, Allergy and Immunology, Cardiovascular Medicine, Emergency Medicine, Endocrinology and Diabetes, Family Medicine, Gastroenterology and Hepatology, Hematology, Infectious Diseases, Nephrology and